{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:46:24Z","timestamp":1780335984872,"version":"3.54.1"},"reference-count":11,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["eJHaem"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report a case of a 45\u2010year\u2010old female who developed an ALK\u2010positive anaplastic large cell lymphoma (ALCL) 9 years after renal transplant. The patient underwent a cadaveric renal transplant for diabetic nephropathy, and presented 9 years later with fever and multiorgan dysfunction. The initial CT scans showed multiple enlarged supra\u2010 and infradiaphrgamatic lymph nodes. A CT\u2010guided core needle biopsy of a retroperitoneal lymph node revealed ALK positive ALCL. She received six cycles of cyclophosphamide, adriamycin, vincristine, etoposide, and prednisone, and has been in remission for over 3 years. Monomorphic T\u2010cell posttransplant lymphoproliferative disorder (PTLD) is an established but rare entity of PTLD and generally carries poor prognosis. This is a case report of a late PTLD with pathology reporting an aggressive T\u2010cell lymphoma that has been successfully treated with multiagent chemotherapy.<\/jats:p>","DOI":"10.1002\/jha2.13","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T10:34:46Z","timestamp":1594377286000},"page":"364-367","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anaplastic large cell lymphoma as a posttransplant lymphoproliferative disorder in a renal transplant patient: A case report"],"prefix":"10.1002","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0341-2396","authenticated-orcid":false,"given":"Manar","family":"Alabdulbaqi","sequence":"first","affiliation":[{"name":"Department of Hematology The Ottawa Hospital  Ottawa Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Toupin","sequence":"additional","affiliation":[{"name":"Department of Hematology Ottawa Hospital General Campus  Ottawa Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Berardi","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology\/Hematopathology Ottawa Hospital General Campus  Ottawa Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleigh","family":"McCurdy","sequence":"additional","affiliation":[{"name":"Department of Hematology University of Ottawa  Ottawa Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"crossref","unstructured":"DierickxD TousseynT GheysensO.How I Treat How I treat posttransplant lymphoproliferative disorders Case reports.2019;126(20):2274\u20132284.https:\/\/doi.org\/10.1182\/blood-2015-05-615872.","DOI":"10.1182\/blood-2015-05-615872"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","unstructured":"SingaviAK HarringtonAM FenskeTS.Post\u2010transplant Lymphoproliferative Disorders.2015;(33):305\u2013327.https:\/\/doi.org\/10.1007\/978-3-319-13150-4_13","DOI":"10.1007\/978-3-319-13150-4_13"},{"key":"e_1_2_5_4_1","doi-asserted-by":"crossref","unstructured":"CampoE PileriS GhielminiM SallesGA ZelenetzAD JaffeES.WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues The 2016 revision of the World Health Organization classification of lymphoid neoplasms.2008;127(June 2016):2375\u20132391.https:\/\/doi.org\/10.1182\/blood-2016-01-643569.","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","unstructured":"SchramAM BerlinerN.How I Treat How I treat hemophagocytic lymphohistiocytosis in the adult patient.2015;125(19):2908\u20132914.https:\/\/doi.org\/10.1182\/blood-2015-01-551622.","DOI":"10.1182\/blood-2015-01-551622"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","unstructured":"CheungCY KamM MaM ChauKF ChakWL.Posttransplant lymphoproliferative disorders in kidney transplant recipients : a retrospective cohort analysis over two decades in Hong Kong.2017;8(57):96903\u201396912.","DOI":"10.18632\/oncotarget.18890"},{"issue":"10","key":"e_1_2_5_7_1","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2012.43.2344","article-title":"Post\u2010Transplantation Lymphoproliferative Disorder After Kidney Transplantation : Report of a Nationwide French Registry and the Development of a New Prognostic Score","volume":"31","author":"Caillard S","year":"2019","journal-title":"J Clin Oncol"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2006.00712.x"},{"key":"e_1_2_5_9_1","doi-asserted-by":"crossref","unstructured":"WeyEA SmithLB.Anaplastic large cell lymphoma (monomorphic post\u2010transplant lymphoproliferative disorder) presenting in gallbladder.2011;(December 2008):17\u201320.https:\/\/doi.org\/10.1007\/s12308-010-0080-6","DOI":"10.1007\/s12308-010-0080-6"},{"key":"e_1_2_5_10_1","doi-asserted-by":"crossref","unstructured":"Transplant P Large A. and Transplantation.2009;20(4):646\u2013651.","DOI":"10.1097\/SCS.0b013e318193d48d"},{"issue":"21","key":"e_1_2_5_11_1","article-title":"Fast Achievement Of a First Metabolic Complete Remission In a Lung Transtplanted Patient With Multiple Comorbidities and a CD30 Positive Anaplastic Large Cell Post\u2010Transplant Lymphoproliferative Disorder (TPTLD\/ALCL) By Treatment With Brentuximab Ved\u2026","volume":"122","author":"Kreczy A","year":"2013","journal-title":"Blood"},{"key":"e_1_2_5_12_1","doi-asserted-by":"crossref","unstructured":"HorwitzS ConnorOAO ProB et\u00a0al.HHS Public Access.2020;393(10168):229\u2013240.https:\/\/doi.org\/10.1016\/S0140-6736(18)32984-2.","DOI":"10.1016\/S0140-6736(18)32984-2"}],"container-title":["eJHaem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjha2.13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jha2.13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jha2.13","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jha2.13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T05:19:58Z","timestamp":1693891198000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jha2.13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1002\/jha2.13"],"URL":"https:\/\/doi.org\/10.1002\/jha2.13","archive":["Portico"],"relation":{},"ISSN":["2688-6146","2688-6146"],"issn-type":[{"value":"2688-6146","type":"print"},{"value":"2688-6146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"2020-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}